APD
47
-2
VLO
33
4
O
35
5
LUV
39
-5
TRV
46
-3
HP
36
3
LEG
28
6
RIG
60
5
STZ
50
7
PEP
47
3
NKE
28
-2
ILMN
64
4
DVN
43
7
CHRW
50
13
RSG
60
3
USB
44
-2
VZ
32
-2
DNB
66
2
AMAT
40
-3
AME
62
3
APD
47
-2
VLO
33
4
O
35
5
LUV
39
-5
TRV
46
-3
HP
36
3
LEG
28
6
RIG
60
5
STZ
50
7
PEP
47
3
NKE
28
-2
ILMN
64
4
DVN
43
7
CHRW
50
13
RSG
60
3
USB
44
-2
VZ
32
-2
DNB
66
2
AMAT
40
-3
AME
62
3
Financhill
Back

Harvard Bioscience Vs. Viking Therapeutics Industry Stock Comparison

Sell
43

HBIO
Harvard Bioscience

Last Price:
2.37
Seasonality Move:
6.31%
Sell
45

VKTX
Viking Therapeutics

Last Price:
63.15
Seasonality Move:
38.04%
Sell
43
Harvard Bioscience (HBIO) is a Sell

Is Harvard Bioscience a Buy, Sell or Hold?

  • The current Harvard Bioscience [HBIO] share price is $2.36. The Score for HBIO is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • HBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Viking Therapeutics (VKTX) is a Sell

Is Viking Therapeutics a Buy, Sell or Hold?

  • The current Viking Therapeutics [VKTX] share price is $63.14. The Score for VKTX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HBIO Stock Price Chart

What is Harvard Bioscience's stock price today?

  • The Harvard Bioscience share price today is $2.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HBIO is experiencing selling pressure, which indicates risk of future bearish movement.

VKTX Stock Price Chart

What is Viking Therapeutics's stock price today?

  • The Viking Therapeutics share price today is $63.14
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing selling pressure, which indicates risk of future bearish movement.

HBIO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 42.4 Sell
Chaikin Money Flow: -48491 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.35 - 2.51) Sell
Bollinger Bands (100): (2.52 - 3.1) Sell

VKTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.92 Buy
Relative Strength Index (14 RSI): 44.37 Sell
Chaikin Money Flow: -27799915 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (62.04 - 71.46) Sell
Bollinger Bands (100): (52.9 - 66.58) Buy

HBIO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.39 Sell
20-day SMA: 2.4 Sell
50-day SMA: 2.63 Sell
200-day SMA: 3.42 Sell
8-day EMA: 2.39 Sell
20-day EMA: 2.43 Sell
50-day EMA: 2.59 Sell
200-day EMA: 3.26 Sell

VKTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 72.43 Sell
20-day SMA: 67.48 Sell
50-day SMA: 64.43 Sell
200-day SMA: 59.82 Buy
8-day EMA: 69.69 Sell
20-day EMA: 68.14 Sell
50-day EMA: 65.07 Sell
200-day EMA: 55.33 Buy

Harvard Bioscience Earnings Growth & HBIO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.08 per share, and an increase next year of $0.08 per share.

Viking Therapeutics Earnings Growth & VKTX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.04 per share, and a decrease next year of $0.50 per share.

Harvard Bioscience Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Viking Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):